# Supplementary Figure 6
MOAlmanac inspects preclinical efficacy of highlighted relationships.

![Supplementary Figure 6](supplementary-figure-6.svg)

Sensitivity of Pictilisib on cancer cell lines for all PIK3CA mutations, all PIK3CA somatic variants, PIK3CA missense variants, and PIK3CA p.H1047R shown.
